US Bancorp’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $871K | Buy |
|
|||||
|
2025
Q2 | $812K | Sell |
|
|||||
|
2025
Q1 | $1.25M | Sell |
|
|||||
|
2024
Q4 | $1.69M | Sell |
|
|||||
|
2024
Q3 | $2.7M | Sell |
|
|||||
|
2024
Q2 | $4.46M | Sell |
|
|||||
|
2024
Q1 | $5.91M | Sell |
|
|||||
|
2023
Q4 | $5.83M | Sell |
|
|||||
|
2023
Q3 | $5.17M | Buy |
|
|||||
|
2023
Q2 | $5.42M | Sell |
|
|||||
|
2023
Q1 | $5.49M | Sell |
|
|||||
|
2022
Q4 | $8.11M | Sell |
|
|||||
|
2022
Q3 | $7.41M | Buy |
|
|||||
|
2022
Q2 | $5.7M | Buy |
|
|||||
|
2022
Q1 | $7.53M | Buy |
|
|||||
|
2021
Q4 | $9.07M | Buy |
|
|||||
|
2021
Q3 | $9.85M | Sell |
|
|||||
|
2021
Q2 | $8.86M | Sell |
|
|||||
|
2021
Q1 | $6.97M | Buy |
|
|||||
|
2020
Q4 | $5.94M | Sell |
|
|||||
|
2020
Q3 | $5.65M | Sell |
|
|||||
|
2020
Q2 | $4.6M | Sell |
|
|||||
|
2020
Q1 | $3.53M | Buy |
|
|||||
|
2019
Q4 | $3.98M | Sell |
|
|||||
|
2019
Q3 | $3.71M | Buy |
|
|||||
|
2019
Q2 | $3.9M | Buy |
|
|||||
|
2019
Q1 | $3.59M | Sell |
|
|||||
|
2018
Q4 | $2.98M | Sell |
|
|||||
|
2018
Q3 | $3.83M | Sell |
|
|||||
|
2018
Q2 | $3.22M | Sell |
|
|||||
|
2018
Q1 | $3.23M | Buy |
|
|||||
|
2017
Q4 | $2.67M | Buy |
|
|||||
|
2017
Q3 | $1.97M | Buy |
|
|||||
|
2017
Q2 | $281K | Hold |
|
|||||
|
2017
Q1 | $248K | Sell |
|
|||||
|
2016
Q4 | $217K | Buy |
|
|||||
|
2016
Q3 | $227K | Sell |
|
|||||
|
2016
Q2 | $237K | Sell |
|
|||||
|
2016
Q1 | $236K | Sell |
|
|||||
|
2015
Q4 | $252K | Sell |
|
|||||
|
2015
Q3 | $243K | Sell |
|
|||||
|
2015
Q2 | $414K | Sell |
|
|||||
|
2015
Q1 | $562K | Sell |
|
|||||
|
2014
Q4 | $463K | Buy |
|
|||||
|
2014
Q3 | $387K | Buy |
|
|||||
|
2014
Q2 | $235K | Buy |
|
|||||
|
2014
Q1 | $229K | Buy |
|
|||||
|
2013
Q4 | $177K | Sell |
|
|||||
|
2013
Q3 | $355K | Buy |
|
|||||
|
2013
Q2 | $115K | Buy |
|